This report focuses on pharmaceutical products for female-related diseases.
The global Women's Health market was valued at US$ 31880 million in 2023 and is anticipated to reach US$ 45040 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
The main companies of Global Women's Health include Amgen, Bayer, Merck KGaA, etc. These top three companies hold a market share about 20%. Europe and North America are the leading production regions in the world. The product is mainly used in contraceptive pills.
This report aims to provide a comprehensive presentation of the global market for Women's Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women's Health.
Report Scope
The Women's Health market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Women's Health market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Women's Health companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceutical Group
Foundation Consumer Healthcare
Zhejiang Xianju Pharmaceutical
Zizhu Pharmaceutical
Qianjin Pharmaceutical
Segment by Type
Hormone Therapy
Nonhormonal Therapy
Segment by Application
Climacteric
Postmenopausal Osteoporosis
Contraceptive Pill
Infertility
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Women's Health companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women's Health Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hormone Therapy
1.2.3 Nonhormonal Therapy
1.3 Market by Application
1.3.1 Global Women's Health Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Climacteric
1.3.3 Postmenopausal Osteoporosis
1.3.4 Contraceptive Pill
1.3.5 Infertility
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Women's Health Market Perspective (2019-2030)
2.2 Women's Health Growth Trends by Region
2.2.1 Global Women's Health Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Women's Health Historic Market Size by Region (2019-2024)
2.2.3 Women's Health Forecasted Market Size by Region (2025-2030)
2.3 Women's Health Market Dynamics
2.3.1 Women's Health Industry Trends
2.3.2 Women's Health Market Drivers
2.3.3 Women's Health Market Challenges
2.3.4 Women's Health Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Women's Health Players by Revenue
3.1.1 Global Top Women's Health Players by Revenue (2019-2024)
3.1.2 Global Women's Health Revenue Market Share by Players (2019-2024)
3.2 Global Women's Health Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Women's Health Revenue
3.4 Global Women's Health Market Concentration Ratio
3.4.1 Global Women's Health Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women's Health Revenue in 2023
3.5 Women's Health Key Players Head office and Area Served
3.6 Key Players Women's Health Product Solution and Service
3.7 Date of Enter into Women's Health Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Women's Health Breakdown Data by Type
4.1 Global Women's Health Historic Market Size by Type (2019-2024)
4.2 Global Women's Health Forecasted Market Size by Type (2025-2030)
5 Women's Health Breakdown Data by Application
5.1 Global Women's Health Historic Market Size by Application (2019-2024)
5.2 Global Women's Health Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Women's Health Market Size (2019-2030)
6.2 North America Women's Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Women's Health Market Size by Country (2019-2024)
6.4 North America Women's Health Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Women's Health Market Size (2019-2030)
7.2 Europe Women's Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Women's Health Market Size by Country (2019-2024)
7.4 Europe Women's Health Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Women's Health Market Size (2019-2030)
8.2 Asia-Pacific Women's Health Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Women's Health Market Size by Region (2019-2024)
8.4 Asia-Pacific Women's Health Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Women's Health Market Size (2019-2030)
9.2 Latin America Women's Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Women's Health Market Size by Country (2019-2024)
9.4 Latin America Women's Health Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Women's Health Market Size (2019-2030)
10.2 Middle East & Africa Women's Health Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Women's Health Market Size by Country (2019-2024)
10.4 Middle East & Africa Women's Health Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Women's Health Introduction
11.1.4 Amgen Revenue in Women's Health Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Women's Health Introduction
11.2.4 Bayer Revenue in Women's Health Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Women's Health Introduction
11.3.4 Merck KGaA Revenue in Women's Health Business (2019-2024)
11.3.5 Merck KGaA Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Detail
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Women's Health Introduction
11.4.4 Merck & Co Revenue in Women's Health Business (2019-2024)
11.4.5 Merck & Co Recent Development
11.5 Ferring
11.5.1 Ferring Company Detail
11.5.2 Ferring Business Overview
11.5.3 Ferring Women's Health Introduction
11.5.4 Ferring Revenue in Women's Health Business (2019-2024)
11.5.5 Ferring Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Women's Health Introduction
11.6.4 Eli Lilly Revenue in Women's Health Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Women's Health Introduction
11.7.4 Pfizer Revenue in Women's Health Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Women's Health Introduction
11.8.4 AbbVie Revenue in Women's Health Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Women's Health Introduction
11.9.4 Abbott Revenue in Women's Health Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Theramex
11.10.1 Theramex Company Detail
11.10.2 Theramex Business Overview
11.10.3 Theramex Women's Health Introduction
11.10.4 Theramex Revenue in Women's Health Business (2019-2024)
11.10.5 Theramex Recent Development
11.11 Livzon Pharmaceutical Group
11.11.1 Livzon Pharmaceutical Group Company Detail
11.11.2 Livzon Pharmaceutical Group Business Overview
11.11.3 Livzon Pharmaceutical Group Women's Health Introduction
11.11.4 Livzon Pharmaceutical Group Revenue in Women's Health Business (2019-2024)
11.11.5 Livzon Pharmaceutical Group Recent Development
11.12 Foundation Consumer Healthcare
11.12.1 Foundation Consumer Healthcare Company Detail
11.12.2 Foundation Consumer Healthcare Business Overview
11.12.3 Foundation Consumer Healthcare Women's Health Introduction
11.12.4 Foundation Consumer Healthcare Revenue in Women's Health Business (2019-2024)
11.12.5 Foundation Consumer Healthcare Recent Development
11.13 Zhejiang Xianju Pharmaceutical
11.13.1 Zhejiang Xianju Pharmaceutical Company Detail
11.13.2 Zhejiang Xianju Pharmaceutical Business Overview
11.13.3 Zhejiang Xianju Pharmaceutical Women's Health Introduction
11.13.4 Zhejiang Xianju Pharmaceutical Revenue in Women's Health Business (2019-2024)
11.13.5 Zhejiang Xianju Pharmaceutical Recent Development
11.14 Zizhu Pharmaceutical
11.14.1 Zizhu Pharmaceutical Company Detail
11.14.2 Zizhu Pharmaceutical Business Overview
11.14.3 Zizhu Pharmaceutical Women's Health Introduction
11.14.4 Zizhu Pharmaceutical Revenue in Women's Health Business (2019-2024)
11.14.5 Zizhu Pharmaceutical Recent Development
11.15 Qianjin Pharmaceutical
11.15.1 Qianjin Pharmaceutical Company Detail
11.15.2 Qianjin Pharmaceutical Business Overview
11.15.3 Qianjin Pharmaceutical Women's Health Introduction
11.15.4 Qianjin Pharmaceutical Revenue in Women's Health Business (2019-2024)
11.15.5 Qianjin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Amgen
Bayer
Merck KGaA
Merck & Co
Ferring
Eli Lilly
Pfizer
AbbVie
Abbott
Theramex
Livzon Pharmaceutical Group
Foundation Consumer Healthcare
Zhejiang Xianju Pharmaceutical
Zizhu Pharmaceutical
Qianjin Pharmaceutical
*If Applicable.